TNF Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Property, Plant and Equipment

Property, Plant and Equipment

9 Months Ended

Sep. 30, 2014

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment

Note 5 - Property, Plant and Equipment

Property, plant and equipment as of September 30, 2014 and December 31, 2013 are as follows:

	2014		2013

Computer Equipment	$	100,405	$	100,405
Computer Software		30,736		22,930
Office Equipment		50,049		50,049
Furniture & Fixtures		29,939		29,939
Machinery & Equipment		1,111,004		1,098,503
Molds & Dies		654,327		649,647
Leasehold Improvements		222,594		222,594
		2,199,054		2,174,067
Less
Accumulated Depreciation		1,974,339		1,906,746

	$	224,715	$	267,321

Depreciation expense was $23,233 and $67,593 for the three and nine months ended September 30, 2014 and $24,870 and $71,869 for the three and nine months ended September 30, 2013.

- Definition

The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.

+ References + Details